LY86 and heart failure: Our previous studies found that MD1 expression was downregulated in heart failure patients [6,7], and loss of MD1 could worsen structural and electrical remodeling under pressure overload and ischemia/reperfusion injury conditions via increased the activation of the TLR4 signaling pathway [6,8].